Department of Anatomy and Cell Biology, University of Western Ontario, London, ON, Canada.
Adv Exp Med Biol. 2013;961:433-47. doi: 10.1007/978-1-4614-4756-6_37.
Stroke is a very strong risk factor for dementia. Furthermore, ischemic stroke and Alzheimer's disease (AD) share a number of overlapping mechanisms of neuron loss and dysfunction, including those induced by the inappropriate activation of N-methyl-D-aspartate receptors (NMDARs). These receptors form a major subtype of excitatory glutamate receptor. They are nonselective cation channels with appreciable Ca(2+) permeability, and their overactivation leads to neurotoxicity in the cortex and hippocampus. NMDARs have therefore been therapeutic targets in both conditions, but they have failed in the treatment of stroke, and there is limited rationale for using them in treating AD. In this chapter, we discuss current understanding of subtypes of NMDARs and their potential roles in -ischemic stroke and AD. We also discuss the properties of several other nonselective cation channels, transient receptor potential melastatin 2 and 7 channels, and their implications in linking these conditions.
中风是痴呆的一个非常强的危险因素。此外,缺血性中风和阿尔茨海默病(AD)共享许多神经元丧失和功能障碍的重叠机制,包括由 N-甲基-D-天冬氨酸受体(NMDAR)的不适当激活引起的机制。这些受体形成兴奋性谷氨酸受体的主要亚型。它们是非选择性阳离子通道,具有相当大的 Ca(2+)通透性,它们的过度激活导致皮质和海马体的神经毒性。因此,NMDAR 一直是这两种情况的治疗靶点,但它们在中风治疗中失败了,并且在治疗 AD 中使用它们的理由有限。在本章中,我们讨论了 NMDAR 亚型的当前理解及其在缺血性中风和 AD 中的潜在作用。我们还讨论了几种其他非选择性阳离子通道、瞬时受体电位 melastatin 2 和 7 通道的特性,以及它们在连接这些情况中的意义。